We are live on ! Find out more
JNJ icon

Johnson & Johnson

1,976 hedge funds and large institutions have $198B invested in Johnson & Johnson in 2014 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 732 increasing their positions, 972 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 41

8% more capital invested

Capital invested by funds: $185B → $198B (+$13.9B)

2% more funds holding in top 10

Funds holding in top 10: 675688 (+13)

0.49% more ownership

Funds ownership: 66.51%67% (+0.49%)

0% more funds holding

Funds holding: 1,9731,976 (+3)

25% less repeat investments, than reductions

Existing positions increased: 732 | Existing positions reduced: 972

26% less call options, than puts

Call options by funds: $1.09B | Put options by funds: $1.48B

Holders
1,976
Holders Change
+3
Holders Change %
+0.15%
% of All Funds
56.77%
Holding in Top 10
688
Holding in Top 10 Change
+13
Holding in Top 10 Change %
+1.93%
% of All Funds
19.76%
New
54
Increased
732
Reduced
972
Closed
41
Calls
$1.09B
Puts
$1.48B
Net Calls
-$385M
Net Calls Change
-$512M
Name Holding Trade Value Shares
Change
Change in
Stake
SM
626
Stratton Management
Pennsylvania
$13M -$321K -3,174 -2%
CCA
627
Cobblestone Capital Advisors
New York
$12.9M -$373K -3,691 -3%
ACP
628
Ashfield Capital Partners
California
$12.9M -$198K -1,954 -2%
ACM
629
Academy Capital Management
Texas
$12.9M -$108K -1,070 -0.9%
CAM
630
Cypress Asset Management
Texas
$12.9M -$464K -4,592 -4%
MWAC
631
Mariner Wealth Advisors (Cincinnati)
Ohio
$12.8M +$747K +7,388 +6%
CVM
632
Cheviot Value Management
California
$12.7M -$303K -2,994 -2%
CTA
633
Colonial Trust Advisors
South Carolina
$12.6M -$211K -2,089 -2%
DCLA
634
Douglas C. Lane & Associates
New York
$12.6M -$2.76M -27,348 -18%
CA
635
CapWealth Advisors
Tennessee
$12.6M +$418K +4,138 +4%
AIM
636
abrdn Investment Management
United Kingdom
$12.6M -$514K -5,081 -4%
KFS
637
Kurt F. Somerville
$12.5M -$233K -2,306 -2%
APFBOT
638
Amica Pension Fund Board of Trustees
Rhode Island
$12.5M -$1.21M -11,959 -9%
1SB
639
1ST Source Bank
Indiana
$12.4M +$143K +1,417 +1%
Millennium Management
640
Millennium Management
New York
$12.4M +$9.12M +90,183 +319%
TSW
641
Thompson Siegel & Walmsley
Virginia
$12.4M -$3.2M -31,680 -21%
MVIP
642
Mar Vista Investment Partners
California
$12.4M -$4.49M -44,469 -27%
KLC
643
Knowledge Leaders Capital
Colorado
$12.3M -$907K -8,970 -7%
MI
644
Markston International
New York
$12.3M -$50.5K -500 -0.4%
EWA
645
EP Wealth Advisors
California
$12.3M +$595K +5,884 +5%
CCFCSB
646
Cape Cod Five Cents Savings Bank
Massachusetts
$12.2M +$8.69K +86 +0.1%
VCM
647
Violich Capital Management
California
$12.2M +$10.1K +100 +0.1%
WT
648
Washington Trust
Rhode Island
$12.1M -$43.3K -428 -0.4%
Marshall Wace
649
Marshall Wace
United Kingdom
$12.1M +$5.3M +52,481 +83%
CL
650
Croft-Leominster
Maryland
$12.1M -$1.39M -13,724 -11%

JNJ Hedge Fund Activity: Q2 2014 in Review

1,976 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q2 2014, worth a combined $198B — up 7.5% from $185B a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new JNJ positions and 41 closed out — a net gain of 13 holders — while 732 added to existing stakes and 972 trimmed.

The largest buyer was Norges Bank, adding an estimated $2.09B. The largest seller was Grantham, Mayo, Van Otterloo & Co (GMO), cutting an estimated $331M.

  • 1,976 institutional investors held Johnson & Johnson (JNJ) as of Q2 2014, up from 1,973 in Q1 2014.
  • Funds reported $198B of Johnson & Johnson stock for Q2 2014, up 7.5% quarter-over-quarter.
  • 54 funds opened new Johnson & Johnson positions in Q2 2014 and 41 closed out, a net change of +13 holders.
  • The largest Johnson & Johnson buyer in Q2 2014 was Norges Bank, an estimated $2.09B added.
  • The largest Johnson & Johnson seller in Q2 2014 was Grantham, Mayo, Van Otterloo & Co (GMO), an estimated $331M sold.

Based on aggregated 13F filings for Q2 2014.